Cobicistat
Specifications
1004316-88-4CAS Number
1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[[(2S)-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]-4-morpholin-4-ylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamateIUPAC Name
C40H53N7O5S2Chemical Formula
776 g/molMolecular Weight
Cobicistat; 1004316-88-4; GS-9350; Tybost; GS 9350; cobicistatum; 2,7,10,12-Tetraazatridecanoic acid, 12-methyl-13-[2-(1-methylethyl)-4-thiazolyl]-9-[2-(4-morpholinyl)ethyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)-; LW2E03M5PG; COBICISTAT, (R,R,S)-; CHEBI:72291; 1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[[(2S)-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]-4-morpholin-4-ylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate; DTXSID00143269; EVOTAZ COMPONENT COBICISTAT; GENVOYA COMPONENT COBICISTAT; SYMTUZA COMPONENT COBICISTAT; REZOLSTA COMPONENT COBICISTAT; STRIBILD COMPONENT COBICISTAT; PREZCOBIX COMPONENT COBICISTAT; 1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2S)-2-({[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}amino)-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl]carbamate; 2,7,10,12-Tetraazatridecanoic acid, 12-methyl-13-(2-(1-methylethyl)-4-thiazolyl)-9-(2-(4-morpholinyl)ethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)-; 1,3-thiazol-5-ylmethyl ((2R,5R)-5-(((2S)-2-((((2-isopropyl-1,3-thiazol-4-yl)methyl)(methyl)carbamoyl)amino)-4-(morpholin-4-yl)butanoyl)amino)-1,6-diphenylhexan-2-yl)carbamate; 1,3-thiazol-5-ylmethyl N-((2R,5R)-5-(((2S)-2-((methyl-((2-propan-2-yl-1,3-thiazol-4-yl)methyl)carbamoyl)amino)-4-morpholin-4-ylbutanoyl)amino)-1,6-diphenylhexan-2-yl)carbamate; GS9350; 9350, GS; RefChem:56763; DTXCID1065760; V03AX03; Cobicistat (GS-9350); MFCD18251449; Cobicistat,GS-9350; thiazol-5-ylmethyl ((2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanamido)-1,6-diphenylhexan-2-yl)carbamate; C40H53N7O5S2; UNII-LW2E03M5PG; thiazol-5-ylmethyl N-[(1R,4R)-1-benzyl-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-4-morpholino-butanoyl]amino]-5-phenyl-pentyl]carbamate; Cobicistat [USAN]; Cobicistat [USAN:INN]; 2,7,10,12-Tetraazatridecanoic acid, 12-methyl-13-[2-(1-methylethyl)-4-thiazolyl]-9-[2-(4-morpholinyl)ethyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)-; Cobicistat; GS 9350; thiazol-5-ylmethyl (2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanamido)-1,6-diphenylhexan-2-ylcarbamate; Tybost (TN); COBI; Cobicistat (Standard); A1APA; COBICISTAT [MI]; COBICISTAT [INN]; COBICISTAT [JAN]; Cobicistat; GS-9350; COBICISTAT [VANDF]; COBICISTAT [WHO-DD]; Cobicistat on silicon dioxide; Cobicistat (JAN/USAN/INN); GTPL7535; orb1227176; orb1300941; SCHEMBL2736227; CHEMBL2095208; COBICISTAT [ORANGE BOOK]; ZCIGNRJZKPOIKD-CQXVEOKZSA-N; GLXC-90002; EX-A2578; BDBM50447471; EBC-27460; HY-10493R; s2900; AKOS025404908; CCG-270459; CS-0742; DB09065; FM40808; NCGC00386235-04; NCGC00386235-06; (1,3-thiazol-5-yl)methyl N-[(2R,5R)-5-[(2S)-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}-4-(morpholin-4-yl)butanamido]-1,6-diphenylhexan-2-yl]carbamate; AC-28961; AS-17061; DA-72306; HY-10493; SY111951; SW219553-1; T6246; D09881; AB01566899_01; EN300-7404993; F794409; Q5138908; BRD-K51040301-001-02-1; (1,3-THIAZOL-5-YL)METHYL (5S,8R,11R)-8,11-DIBENZYL-2-METHYL-5-(2-(MORPHOLIN-4-YL)ETHYL)-1-(2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL)-3,6-DIOXO-2,4,7,12-TETRAAZATRIDECAN-13-OATE; (1,3-Thiazol-5-yl)methyl {(2R,5R)-5-[(2S)-2-[(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)amino]-4-(morpholin-4-yl)butanamido]-1,6-diphenylhexan-2-yl}carbamate; (3R,6R,9S)-12-Methyl-13-[2-(1-methylethyl)-4-thiazolyl]-9-[2-(4-morpholinyl)ethyl]-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic acid 5-thiazolylmethyl ester; (3R,6R,9S)-2-Methyl-13-[2-(1-methylethyl)-4-thiazolyl]-9-[2-(4-morpholin yl)ethyl]-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic acid 5-thiazolylmethyl ester; 1,3-THIAZOL-5-YLMETHYL ((2R,5R)-5-(((2S)-2-((METHYL((2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL)METHYL)CARBAMOYL)AMINO)-4-(MORPHOLIN-4-YL)BUTANOYL)AMINO)-1,6-DIPHENYLHEXAN-2-YL)CARBAMATE; 1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[(2S)-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}-4-(morpholin-4-yl)butanamido]-1,6-diphenylhexan-2-yl]carbamate; 5-Thiazolylmethyl [(2R,5R)-5-[(S)-2-[3-[(2-Isopropyl-4-thiazolyl)methyl]-3-methylureido]-4-morpholinobutanamido]-1,6-diphenyl-2-hexyl]carbamate; Thiazol-5-ylmethyl ((1R,4R)-1-benzyl-4-({(2S)-2-((methyl{(2-(1-methylethyl)thiazol-4-yl)methyl}carbamoyl)amino)-4-(morpholin-4-yl)butanoyl}amino)-5-phenylpentyl)carbamateSynonyms
Products Containing Cobicistat
SYMTUZA 800 MG/150 MG/200 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULASTRIBILD 150MG/150MG/200MG/245MG COMPRIMIDOS RECUBIERTOS CON PELICULAGENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULATYBOST 150mg comprimidos recubiertos con peliculaSTRIBILD 150mg/150mg/200mg/245mg COMPRIMIDOS RECUBIERTOS CON PELICULAGENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULASYMTUZA 800 MG/150 MG/200 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULAREZOLSTA 800 MG/150 MG COMPRIMIDOS RECUBIERTOS CON PELICULAEVOTAZ 300 MG/150 MG COMPRIMIDOS RECUBIERTOS CON PELICULASTRIBILD 150 mg/150 mg/200 mg/245 mg, comprimé pelliculéGENVOYA 150 mg/150 mg/200 mg/10 mg, comprimé pelliculéCobicistat - Matrix Pharmaceutical Inc
Page 1 of 2
Companies Selling Cobicistat
ML
MSN LaboratoriesIndiaZE
Zhejiang Eazy Pharmchem Co., Ltd.ChinaHL
Hangzhou Longshine Bio-TechChinaJI
Janssen-Cilag International N.VSpainBS
Bristol-Myers Squibb Pharma EeigSpainGS
Gilead Sciences Ireland Unlimited CompanySpainPage 1 of 2